GR3034201T3 - Oxidation of steroids having allylic groups - Google Patents

Oxidation of steroids having allylic groups

Info

Publication number
GR3034201T3
GR3034201T3 GR20000401775T GR20000401775T GR3034201T3 GR 3034201 T3 GR3034201 T3 GR 3034201T3 GR 20000401775 T GR20000401775 T GR 20000401775T GR 20000401775 T GR20000401775 T GR 20000401775T GR 3034201 T3 GR3034201 T3 GR 3034201T3
Authority
GR
Greece
Prior art keywords
allylic
steroids
oxidation
allylic groups
delta
Prior art date
Application number
GR20000401775T
Other languages
English (en)
Inventor
Ross A Miller
Andrew S Thompson
Raman K Bakshi
Edward G Corley
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of GR3034201T3 publication Critical patent/GR3034201T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/46—Ruthenium, rhodium, osmium or iridium
    • B01J23/462—Ruthenium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
    • B01J23/56—Platinum group metals
    • B01J23/64—Platinum group metals with arsenic, antimony, bismuth, vanadium, niobium, tantalum, polonium, chromium, molybdenum, tungsten, manganese, technetium or rhenium
    • B01J23/652—Chromium, molybdenum or tungsten
    • B01J23/6527—Tungsten
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR20000401775T 1994-05-19 2000-08-24 Oxidation of steroids having allylic groups GR3034201T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24593594A 1994-05-19 1994-05-19
PCT/US1995/006004 WO1995032215A1 (en) 1994-05-19 1995-05-15 Oxidation of steroids having allylic groups

Publications (1)

Publication Number Publication Date
GR3034201T3 true GR3034201T3 (en) 2000-11-30

Family

ID=22928693

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401775T GR3034201T3 (en) 1994-05-19 2000-08-24 Oxidation of steroids having allylic groups

Country Status (22)

Country Link
US (1) US6369247B1 (el)
EP (1) EP0759929B1 (el)
JP (1) JPH10500682A (el)
KR (1) KR970703359A (el)
CN (1) CN1152316A (el)
AT (1) ATE195741T1 (el)
AU (1) AU688513B2 (el)
BR (1) BR9507663A (el)
CA (1) CA2190500A1 (el)
CZ (1) CZ338896A3 (el)
DE (1) DE69518515T2 (el)
DK (1) DK0759929T3 (el)
ES (1) ES2149365T3 (el)
FI (1) FI964610A0 (el)
GR (1) GR3034201T3 (el)
HU (1) HU223613B1 (el)
NZ (1) NZ287230A (el)
PT (1) PT759929E (el)
RO (1) RO116550B1 (el)
RU (1) RU2149875C1 (el)
SK (1) SK282278B6 (el)
WO (1) WO1995032215A1 (el)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763361A (en) * 1995-10-23 1998-06-09 Merck & Co., Inc. 17-alkyl-7-substituted-4-aza steroid derivatives as 5-α-reductase inhibitors
ATE205193T1 (de) * 1995-10-23 2001-09-15 Merck & Co Inc 17-alkyl-7-substituierte-4-aza-steroidderivate
US5872126A (en) * 1996-09-06 1999-02-16 Merck & Co., Inc. Methods and compositions for treating preterm labor
US6686486B1 (en) 1997-05-07 2004-02-03 Padma Marwah Process for effecting allylic oxidation
US5869709A (en) * 1997-05-07 1999-02-09 Humanetics Corporation Process for effecting allylic oxidation
US6252119B1 (en) * 1997-07-28 2001-06-26 Salvador Jorge Antonio Riberiro Copper-catalysed allylic oxidation using alkyl hydroperoxide
US7012069B2 (en) * 2001-05-03 2006-03-14 Arch Development Corporation Liver X receptor agonists
US6187925B1 (en) 1997-12-23 2001-02-13 Merck & Co., Inc. Intermediates and process for the synthesis of azasteroids
AU3088799A (en) 1998-03-18 1999-10-11 Humanetics Corporation Process for effecting allylic oxidation using dicarboxylic acid imides and chromium reagents
IL146223A0 (en) 1999-04-30 2002-07-25 Arch Dev Corp Steroid derivatives
GB0020286D0 (en) * 2000-08-18 2000-10-04 Univ York Cobalt catalysed allylic oxidation of unsaturated steroids using alkyl hydroperoxide
US7078396B2 (en) * 2001-05-03 2006-07-18 Arch Development Corporation Method of treating disorder related to high cholesterol concentration
US20070197484A1 (en) * 2001-05-03 2007-08-23 Ching Song Method of treating disorder related to high cholesterol concentration
AU2003228485A1 (en) * 2002-04-12 2003-10-27 The University Of Chicago Farnesoid x-activated receptor agonists
US20070032464A1 (en) * 2004-10-08 2007-02-08 Shutsung Liao Methods of treating cancers
CA2600547A1 (en) * 2005-03-10 2006-09-21 Jr Chem, Llc Benzoyl peroxide compositions and methods of use
KR101352187B1 (ko) 2005-03-10 2014-02-17 제이알 켐, 엘엘씨 안정한 유기 퍼옥사이드 조성물
US7556820B2 (en) 2005-06-29 2009-07-07 Jr Chem, Llc Stable organic peroxide compositions
WO2007005471A2 (en) * 2005-06-29 2007-01-11 Jr Chem, Llc Stable organic peroxide compositions
US20090306023A1 (en) * 2005-06-29 2009-12-10 Ramirez Jose E Stable organic peroxide compositions
WO2007002880A2 (en) * 2005-06-29 2007-01-04 Jr Chem, Llc Method of enhanced drug application
CN101619089B (zh) * 2009-07-28 2011-07-20 陈大刚 抗肿瘤药物cl168、其合成方法及应用
EP2459581A4 (en) * 2009-07-29 2012-12-26 Univ Chicago LIVER X-RECEPTOR AGONISTS
WO2012105543A1 (ja) * 2011-01-31 2012-08-09 旭化成ケミカルズ株式会社 混合液製造装置及び混合液調製方法
US9828326B2 (en) 2011-12-27 2017-11-28 Northeast Ohio Medical University Amooranin compounds and analogs thereof and related methods of use
CN105358248A (zh) * 2013-03-15 2016-02-24 佛罗里达州立大学研究基金有限公司 对映黄体酮及其中间产物的合成
CN103788163B (zh) * 2014-01-27 2015-11-18 浙江大学 7-酮基甾类化合物的制备方法
CA3005983A1 (en) 2015-11-23 2017-06-01 Retrotope, Inc. Site-specific isotopic labeling of 1,4-diene systems
CN106008423B (zh) * 2016-06-24 2018-02-02 云南民族大学 一种苯丙素类化合物及其制备方法和应用
CA3172351A1 (en) 2020-02-21 2021-08-26 Retrotope, Inc. Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof
CN118957676B (zh) * 2024-07-29 2026-03-03 中国石油大学(华东) 一种多酸衍生的钨掺杂钌氧化物纳米颗粒电催化剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
GB8422443D0 (en) * 1984-09-05 1984-10-10 British Petroleum Co Plc Oxidation of hydrocarbons
DK173704B1 (da) 1985-04-17 2001-07-09 Hoffmann La Roche Fremgangsmåde til katalytisk oxidation af allyliske grupper
CZ283894A3 (en) 1992-05-20 1995-09-13 Merck & Co Inc 7beta-substituted 4-aza-5alpha-cholestanones, their use for the preparation of pharmaceutical preparations and pharmaceutical compositions containing thereof
IL111467A0 (en) 1993-11-12 1994-12-29 Merck & Co Inc Pharmaceutical compositions comprising 7 beta -substituted -4-aza 5 alpha -cholestan-3-ones and 5 alpha reductase 1 inhibitors

Also Published As

Publication number Publication date
ES2149365T3 (es) 2000-11-01
BR9507663A (pt) 1997-10-07
WO1995032215A1 (en) 1995-11-30
HK1009274A1 (en) 1999-05-28
DE69518515D1 (de) 2000-09-28
CZ338896A3 (en) 1997-07-16
SK282278B6 (sk) 2002-01-07
HU223613B1 (hu) 2004-10-28
US6369247B1 (en) 2002-04-09
HUT75778A (en) 1997-05-28
KR970703359A (ko) 1997-07-03
EP0759929B1 (en) 2000-08-23
FI964610A7 (fi) 1996-11-18
FI964610L (fi) 1996-11-18
NZ287230A (en) 1997-07-27
FI964610A0 (fi) 1996-11-18
DK0759929T3 (da) 2000-11-13
HU9603187D0 (en) 1997-01-28
CA2190500A1 (en) 1995-11-30
AU2588595A (en) 1995-12-18
RO116550B1 (ro) 2001-03-30
EP0759929A4 (en) 1998-09-30
EP0759929A1 (en) 1997-03-05
AU688513B2 (en) 1998-03-12
JPH10500682A (ja) 1998-01-20
SK147896A3 (en) 1997-08-06
ATE195741T1 (de) 2000-09-15
PT759929E (pt) 2001-01-31
CN1152316A (zh) 1997-06-18
DE69518515T2 (de) 2001-04-19
RU2149875C1 (ru) 2000-05-27

Similar Documents

Publication Publication Date Title
GR3034201T3 (en) Oxidation of steroids having allylic groups
DE59709121D1 (de) Verfahren zur herstellung von wasserstoffperoxid
AU556055B2 (en) Treating peroxide containing wastewater
EP0764464A3 (en) Catalyst for production of ethylene oxide
DE59802965D1 (de) Verfahren zur oxidation einer mindestens eine c-c-doppelbindung aufweisenden organischen verbindung
ES8402797A1 (es) "un procedimiento para obtener peroxido de hidrogeno".
TW429163B (en) Oxidazing catalyst system and an oxidation process by using the same
ES8604467A1 (es) Un metodo catalitico mejorado para preparar peroxido de hidrogeno
MY102573A (en) Oxidation of unsaturated organic compounds with hydrogen peroxide
DE69402556D1 (de) Herstellung von n-phosphonomethylglysin und derensalze
MX9605718A (es) Oxidacion de esteroides que tienen grupos alilicos.
AU630289B2 (en) Process for the production of alkyltetrahydroanthrahydroquinones and working solutions containing the latter for the production of hydrogen peroxide according to the anthraquinone process
ES2114179T3 (es) Oxidacion de cetonas.
KR890012959A (ko) 3-(2-히드로페록시-2-프로필)페놀 및 이를 이용한 레조르시놀의 제조 방법
EP0934114B8 (en) Promoted silver catalyst
ES2137831A1 (es) Procedimiento de productos de peroxido de hidrogeno mediante oxidacion de alcoholes secundarios con oxigeno molecular en fase liquida.
ES314231A1 (es) Procedimiento para la elaboracion de subestratos oxidados.
EP0159755A3 (en) Isomerization of tertiary olefins
IT1304175B1 (it) Metodo di attivazione della titanio silicalite e suo impiego inprocessi di ossidazione con acqua ossigenata.
UA32517C2 (uk) Каталізатор для одержання вінілацетату
GB2333523A (en) Metallacarboranes
UA7815A1 (uk) Каталізатор для окислення олефінів с - с 3 4

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees